Sensus Healthcare (SRTS) Net Margin (2016 - 2025)
Sensus Healthcare's (SRTS) quarterly Net Margin came in at 64.12% in Q4 2025, down 7595.0% year-on-year from 0.86% in Q4 2024, and down 368.1% quarter-over-quarter from 13.7% in Q3 2025.
Sensus Healthcare (SRTS) Net Margin (2016 - 2025) Analysis & Trends
Sensus Healthcare's Net Margin history runs 10 years deep, the most recent figure standing at 64.12% for Q4 2025.
- On a quarterly basis, Net Margin fell 7595.0% year-over-year to 64.12% in Q4 2025; TTM through Dec 2025 was 28.09%, a 4399.0% decrease from a year earlier, with the FY2025 full-year figure at 28.09%, down 4399.0% from the prior year.
- Net Margin slipped to 64.12% in Q4 2025 per SRTS's latest filing, from 13.7% in the prior quarter.
- Across five years, Net Margin topped out at 40.83% in Q4 2021 and bottomed at 6106.5% in Q1 2022.
- The 5-year median for Net Margin is 0.81% (2021), against an average of 307.93%.
- Across the five-year window, Net Margin tumbled 607018 bps in 2022 and soared 605102 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 40.83% in 2021, then slumped by 47 bps to 21.59% in 2022, then jumped by 55 bps to 33.5% in 2023, then slumped by 65 bps to 11.83% in 2024, then plunged by 642 bps to 64.12% in 2025.
- Per Business Quant, the three latest SRTS Net Margin figures stand at 64.12% (Q4 2025), 13.7% (Q3 2025), and 14.18% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -64.12% |
| Sep 30, 2025 | -13.70% |
| Jun 30, 2025 | -14.18% |
| Mar 31, 2025 | -30.82% |
| Dec 31, 2024 | 11.83% |
| Sep 30, 2024 | 13.75% |
| Jun 30, 2024 | 17.45% |
| Mar 31, 2024 | 21.33% |
| Dec 31, 2023 | 33.50% |
| Sep 30, 2023 | -37.22% |
| Jun 30, 2023 | -8.39% |
| Mar 31, 2023 | -55.48% |
| Dec 31, 2022 | 21.59% |
| Sep 30, 2022 | 20.30% |
| Jun 30, 2022 | 29.17% |
| Mar 31, 2022 | -6,106.50% |
| Dec 31, 2021 | 40.83% |
| Sep 30, 2021 | 3.53% |
| Jun 30, 2021 | -5.15% |
| Mar 31, 2021 | -36.32% |